Simulations Plus, Inc. Board of Directors

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Mr. William Frederick

Mr. William Frederick

COO, CFO & Secretary

Mr. Steven Chang

Mr. Steven Chang

President of Quantitative Systems Pharmacology

Dr. Bud Nelson J.D., Ph.D.

Dr. Bud Nelson J.D., Ph.D.

VP of Corporate Counsel & Personal Data Protection Officer

Mr. Shawn M. O'Connor

Mr. Shawn M. O'Connor

Chief Executive Officer

Ms. Tanya Marvin

Ms. Tanya Marvin

Marketing Manager

Mr. Daniel Szot

Mr. Daniel Szot

Chief Revenue Officer

Mr. John Anthony DiBella M.S.

Mr. John Anthony DiBella M.S.

President of PBPK & Cheminformatics Solutions

Ms. Lindsay Luke

Ms. Lindsay Luke

Executive Director of Human Resources

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.